
Sign up to save your podcasts
Or


Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.
By The Motley Fool4.7
16041,604 ratings
Abbott Labs hits a new all-time high after the FDA approves the company’s rapid Covid-19 test. Tiffany and Dollar General issue 2nd-quarter reports, offering an interesting look at both ends of the retail spectrum. Jim Gillies analyzes those stories, and shares some compelling reasons why investors looking for steady yield should take a closer look at the “Big Five” banks in Canada.

3,218 Listeners

1,710 Listeners

806 Listeners

946 Listeners

517 Listeners

4,359 Listeners

1,633 Listeners

825 Listeners

5,138 Listeners

675 Listeners

9,522 Listeners

1,030 Listeners

345 Listeners

302 Listeners

1,293 Listeners

1,550 Listeners

79 Listeners